1. Home
  2. FULC vs PKST Comparison

FULC vs PKST Comparison

Compare FULC & PKST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • PKST
  • Stock Information
  • Founded
  • FULC 2015
  • PKST 2008
  • Country
  • FULC United States
  • PKST United States
  • Employees
  • FULC N/A
  • PKST N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • PKST Real Estate Investment Trusts
  • Sector
  • FULC Health Care
  • PKST Real Estate
  • Exchange
  • FULC Nasdaq
  • PKST Nasdaq
  • Market Cap
  • FULC 468.1M
  • PKST 514.0M
  • IPO Year
  • FULC 2019
  • PKST N/A
  • Fundamental
  • Price
  • FULC $11.74
  • PKST $13.72
  • Analyst Decision
  • FULC Buy
  • PKST Strong Buy
  • Analyst Count
  • FULC 7
  • PKST 2
  • Target Price
  • FULC $10.43
  • PKST $17.50
  • AVG Volume (30 Days)
  • FULC 922.1K
  • PKST 190.2K
  • Earning Date
  • FULC 10-29-2025
  • PKST 11-05-2025
  • Dividend Yield
  • FULC N/A
  • PKST 2.92%
  • EPS Growth
  • FULC N/A
  • PKST N/A
  • EPS
  • FULC N/A
  • PKST N/A
  • Revenue
  • FULC N/A
  • PKST $221,496,000.00
  • Revenue This Year
  • FULC N/A
  • PKST N/A
  • Revenue Next Year
  • FULC N/A
  • PKST N/A
  • P/E Ratio
  • FULC N/A
  • PKST N/A
  • Revenue Growth
  • FULC 2752.05
  • PKST 48.03
  • 52 Week Low
  • FULC $2.32
  • PKST $10.14
  • 52 Week High
  • FULC $12.14
  • PKST $15.40
  • Technical
  • Relative Strength Index (RSI)
  • FULC 72.74
  • PKST 48.19
  • Support Level
  • FULC $7.51
  • PKST $13.54
  • Resistance Level
  • FULC $9.05
  • PKST $14.19
  • Average True Range (ATR)
  • FULC 0.80
  • PKST 0.67
  • MACD
  • FULC 0.27
  • PKST -0.06
  • Stochastic Oscillator
  • FULC 89.63
  • PKST 35.41

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.

Share on Social Networks: